Loading
Latest filing published 04 Dec 2025 for Biohit Oyj, €600k.
Biohit Healthcare (Hefei) Co., Ltd discloses dealings in Biohit Oyj to Nasdaq Helsinki. Between 5 November 2025 and 3 December 2025, the trades on record add up to 3 filings.
No open-market purchase appears, only 3 sales worth €4.4M.
On 4 December 2025 came the latest disclosure, an open-market sale for €600k in Biohit Oyj. The median gap between a trade and its publication by Nasdaq Helsinki is 2 days. The legal deadline for notifying a trade is three business days (MAR article 19). A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by Nasdaq Helsinki. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations